Author: Mitchell Gaydash

A collaboration between Institute for In Vitro Sciences (IIVS) and Epithelix has been established to expand access to advanced human-relevant respiratory tissue models within the United States. Through this partnership, IIVS will leverage its logistical experience distributing precision- cut lung slices (PCLS) throughout the country...

As we reflect on the changes and announcements from US and international government agencies this year, we are excited about the opportunities that 2026 will bring. We are deeply grateful to all our contributors, collaborators, clients, and supporters for your continued partnership in advancing science...

We are thrilled to announce that IIVS is now offering the EpiSensA (Epidermal Sensitization Assay) as a GLP-compliant method in our sensitization testing portfolio. EpiSensA offers a reliable, human-relevant method for assessing skin sensitization potential, increasing our ability to provide New Approach Methodology (NAM) testing...

In vitro full-thickness human skin (FT-Skin) models are important tools for testing of cosmetics and chemicals, screening of new pharmaceuticals, and human disease modeling research. However, these skin models commonly utilize animal-derived collagen as a main structural element of the stromal matrix. Animal-derived collagen constructs...

Reproducibility including independent ring trials remain essential for regulatory confidence in NAMs. Validation reform must not compromise data quality, robustness, or legal defensibility. Context of use should be operationalized to distinguish formal regulatory- and flexible case-specific use. Short-cuts on validation risks irreproducibility, regulatory failure,...